Senior Director, US Medical, Head of Real-world Outcomes, Innovative Partnerships & Insights Biogen
Weston Massachusetts        UNITED STATES
Terrie Livingston is the Senior Director, US Medical, Head of Real-world Outcomes, Innovative Partnerships & Insights at Biogen. Dr. Livingston has over 18 years of Managed Care expertise and 14 years of Pharmaceutical/Life Sciences experience. She was a Managing Partner and Vice President of Pharmacy Operations and Business Development for eBioCare, a Specialty Pharmacy in California. She has held various positions with increasing responsibility within the pharmaceutical industry ranging from field roles to development and leadership/management as a Functional Head at Pharmacia, Novartis and most recently Biogen. Currently she is the Head of Innovation and External Partnerships in US Medical at Biogen. Dr. Livingston received her doctorate in Pharmacy from the University of California, San Francisco (UCSF) as well as completion of a general and specialty residency from UCSF. In her current role, Terrie is responsible for strategic engagement and partnerships across all key stakeholders in healthcare that include providers, payers, advocacy organizations, professional societies and healthcare policy makers that focus on collaborations and partnerships that provide innovative solutions to healthcare. Through these partnerships, the goal is real-world data generation across the healthcare ecosystem and to create a framework to continuously engage on innovative initiatives that enable sustainable change to improve patient outcomes and the patient experience. Terrie has M.S. She understands firsthand the experience of other patients living with the disease -- and the challenges of managing a chronic condition while also managing the demands of work and life. Terrie has spoken at events including SXSW, the Georgetown University Patient Reported Outcomes (PROs) for Neurodegenerative Disease Symposium, the BioIT World Annual Conference, the Biomedical Science Careers Student Conference, the Biogen Patient Peer Advisor Annual Meeting, and EyeforPharma.
None yet.